Loading organizations...
§ Private Profile · Bellevue, WA, USA
Medical device developer of body-worn ECG sensing technologies for advanced cardiac diagnostic testing and arrhythmia detection.
Cardiac Insight is a Kirkland, Washington-based medical device company that develops body-worn electrocardiogram sensing technologies and software-assisted analysis tools for advanced cardiac diagnostic testing and arrhythmia detection. The organization provides healthcare institutions, physicians, and cardiologists with diagnostic hardware, including the Cardea SOLO seven-day wearable ambulatory sensor and the Cardea 20/20 handheld 12-lead ECG device. The enterprise has raised at least $17 million in venture capital funding, including a $10 million financing round completed in 2017 to support the commercialization of its disposable wearable sensors. In 2021, the company joined forces with its parent organization, DreamTech, while its executive team and board have included industry figures such as Min Kim, Victor Froelicher, and Clifford J. Stocks. Cardiac Insight was officially founded in 2008 by co-founders Brad Harlow, David Hadley, and David Linker.
Cardiac Insight has raised $15.0M across 3 funding rounds.
Cardiac Insight has raised $15.0M in total across 3 funding rounds.
Cardiac Insight has raised $15.0M in total across 3 funding rounds.
Cardiac Insight's investors include SeaChange Fund.
Cardiac Insight has raised $15.0M across 3 funding rounds. Most recently, it raised $8.0M Series D in February 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 11, 2020 | $8M Series D | SeaChange Fund | — | Announced |
| Apr 22, 2017 | $4.5M Series C | — | — | Announced |
| Apr 29, 2016 | $2.5M Series C | — | — | Announced |